William Blair Comments on Astrana Health Q1 Earnings

Astrana Health, Inc. (NASDAQ:ASTH - Free Report) - Equities research analysts at William Blair issued their Q1 2026 earnings per share estimates for Astrana Health in a research report issued on Wednesday, July 2nd. William Blair analyst R. Daniels anticipates that the company will earn $0.34 per share for the quarter. The consensus estimate for Astrana Health's current full-year earnings is $1.15 per share. William Blair also issued estimates for Astrana Health's Q4 2026 earnings at $0.48 EPS.

Astrana Health (NASDAQ:ASTH - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported $0.14 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.23 by ($0.09). The business had revenue of $620.39 million for the quarter, compared to the consensus estimate of $628.11 million. Astrana Health had a net margin of 1.56% and a return on equity of 4.90%. The company's revenue for the quarter was up 53.4% compared to the same quarter last year. During the same period in the previous year, the company earned $0.31 earnings per share.

Other research analysts also recently issued research reports about the company. Truist Financial lowered their target price on Astrana Health from $50.00 to $46.00 and set a "buy" rating on the stock in a report on Tuesday, March 18th. Barclays initiated coverage on Astrana Health in a report on Tuesday, April 1st. They issued an "equal weight" rating and a $36.00 target price on the stock. Three research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat, Astrana Health currently has an average rating of "Moderate Buy" and a consensus target price of $53.29.

Astrana Health Stock Performance

ASTH stock traded up $0.63 during trading on Thursday, reaching $25.28. The stock had a trading volume of 159,835 shares, compared to its average volume of 297,095. Astrana Health has a 52 week low of $23.12 and a 52 week high of $63.20. The stock's 50 day moving average is $26.65 and its two-hundred day moving average is $30.76. The company has a current ratio of 1.70, a quick ratio of 1.70 and a debt-to-equity ratio of 0.54. The firm has a market cap of $1.42 billion, a PE ratio of 35.10, a PEG ratio of 1.36 and a beta of 0.84.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the stock. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Astrana Health by 348.1% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 37,788 shares of the company's stock worth $1,191,000 after buying an additional 29,355 shares during the period. Truist Financial Corp bought a new position in shares of Astrana Health in the fourth quarter worth about $315,000. Quantbot Technologies LP raised its stake in shares of Astrana Health by 152.5% in the fourth quarter. Quantbot Technologies LP now owns 10,651 shares of the company's stock worth $336,000 after buying an additional 6,433 shares during the period. KLP Kapitalforvaltning AS bought a new position in shares of Astrana Health in the fourth quarter worth about $318,000. Finally, JPMorgan Chase & Co. raised its stake in shares of Astrana Health by 136.1% in the fourth quarter. JPMorgan Chase & Co. now owns 163,532 shares of the company's stock worth $5,156,000 after buying an additional 94,268 shares during the period. Institutional investors own 52.77% of the company's stock.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.